FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

17899311000001109: Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61438201000001116 Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
61438301000001113 Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) 12 tablet Has AMP True Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start